1 |
Chiang T, Hsu H, Chern Y, Liao C, Hsu Y, Tsai W, Hsieh P, Lin Y, Lee H, You J. Skin Toxicity as a Predictor of Survival in Metastatic Colorectal Cancer Patients Treated with Anti-EGFR: Fact or Fallacy? Cancers 2023;15:1663. [DOI: 10.3390/cancers15061663] [Reference Citation Analysis]
|
2 |
Raimondi A, Randon G, Prisciandaro M, Pagani F, Lonardi S, Antoniotti C, Bozzarelli S, Sartore-Bianchi A, Tampellini M, Fanchini L, Murialdo R, Clavarezza M, Zaniboni A, Berenato R, Ratti M, Petrelli F, Antonuzzo L, Giordano M, Rossi A, Di Bartolomeo M, Di Maio M, Pietrantonio F, Morano F. Early onset metastatic colorectal cancer in patients receiving panitumumab-based upfront strategy: Overall and sex-specific outcomes in the Valentino trial. Int J Cancer 2022. [PMID: 35678328 DOI: 10.1002/ijc.34156] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|